Mid-Life Proteinuria and Late-Life Cognitive Function and Dementia in Elderly Men

Alzheimer Disease and Associated Disorders

Volumn 29, Issue 3, 2015, Pages 200-205

  Higuchi, Masaya ^a,d   Chen, Randi ^b   Abbott, Robert D ^a,e   Bell, Christina ^a   Launer, Lenore ^f   Ross, G Webster ^a,c   Petrovitch, Helen ^a,c   Masaki, Kamal ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b KUAKINI MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

cognitive decline; dementia; Japanese American men; longitudinal cohort study; proteinuria

Indexed keywords

APOLIPOPROTEIN E4; CREATININE; GLUCOSE;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; ASIAN AMERICAN; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITION ASSESSMENT; COGNITIVE ABILITIES SCREENING INSTRUMENT; CREATININE BLOOD LEVEL; DEMENTIA; DEMENTIA ASSESSMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; OUTCOME VARIABLE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SELF REPORT; SMOKING; SYSTOLIC BLOOD PRESSURE; URINALYSIS; ASIA; COGNITION DISORDERS; ETHNOLOGY; MIDDLE AGED; ONSET AGE; PHYSIOLOGY; RISK FACTOR;

AGE OF ONSET; AGED; AGING; ALZHEIMER DISEASE; ASIA; ASIAN AMERICANS; COGNITION; COGNITION DISORDERS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS;

EID: 84941022624     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000082     Document Type: Article

References (40)

1. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: A Delphi consensus study. Lancet. 2005;366: 2112-2117.
2. Weiner DE, Bartolomei K, Scott T, et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis. 2009;53:438-447.
3. Yaffe K, Ackerson L, Kurella Tamura M, et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58:338-345.
4. Vupputuri S, Shoham DA, Hogan SL, et al. Microalbumi-nuria, peripheral artery disease, and cognitive function. Kidney Int. 2008;73:341-346.
5. Barzilay JI, Fitzpatrick AL, Luchsinger J, et al. Albuminuria and dementia in the elderly: A community study. Am J Kidney Dis. 2008;52:216-226.
6. Buchman AS, Tanne D, Boyle PA, et al. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009;73:920-927.
7. Slinin Y, Paudel ML, Ishani A, et al. Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc. 2008;56:2082-2088.
8. Jassal SK, Kritz-Silverstein D, Barrett-Connor E. A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol. 2010;171:277-286.
9. Etgen T, Sander D, Chonchol M, et al. Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. Nephrol Dial Transplant. 2009;24: 3144-3150.
10. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2005;16:2127-2133.
11. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive decline in older individuals with diabetes. Diabetes Care. 2008;31:2103-2107.
12. Sasaki Y, Marioni R, Kasai M, et al. Chronic kidney disease: A risk factor for dementia onset: A population-based study. The Osaki-Tajiri Project. J Am Geriatr Soc. 2011;59:1175-1181.
13. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45:1161-1168.
14. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004;15:1904-1911.
15. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemiol. 1984;119:653-666.
16. White L, Petrovitch H, Ross GW, et al. Prevalence ofdementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA. 1996;276:955-960.
17. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psycho-geriatr. 1994;6:45-58; discussion 62.
18. Abbott RD, White LR, Ross GW, et al. Walking and dementia in physically capable elderly men. JAMA. 2004;292:1447-1453.
19. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015-1022.
20. Jorm AF, Scott R, Cullen JS, et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med. 1991;21:785-790.
21. Havlik RJ, Izmirlian G, Petrovitch H, et al. APOE-epsilon4 predicts incident AD in Japanese-American men: the honolulu-asia aging study. Neurology. 2000;54:1526-1529.
22. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
23. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42(pt 1):473-480.
24. Abbott RD, Curb JD, Rodriguez BL, et al. Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. J Clin Epidemiol. 2003;56:479-486.
25. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540-548.
26. Abbott RD, Rodriguez BL, Burchfiel CM, et al. Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. Am J Epidemiol. 1994;139:881-893.
27. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008;52:227-234.
28. Tsai CF, Wang SJ, Fuh JL. Moderate chronic kidney disease is associated with reduced cognitive performance in midlife women. Kidney Int. 2010;78:605-610.
29. Barzilay JI, Gao P, O'Donnell M, et al. Albuminuria and decline in cognitive function: the ONTARGET/TRAN-SCEND studies. Arch Intern Med. 2011;171:142-150.
30. Post JB, Jegede AB, Morin K, et al. Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract. 2010;116:c247-c255.
31. Garg AX, Kiberd BA, Clark WF, et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002;61:2165-2175.
32. O'Hare AM, Walker R, Haneuse S, et al. Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc. 2012;60:2215-2222.
33. Deschamps V, Barberger-Gateau P, Peuchant E, et al. Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology. 2001;20:7-15.
34. Paragh G, Balla P, Katona E, et al. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci. 2002;252:63-67.
35. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci. 2002;977:9-23.
36. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
37. LaunerLJ, MasakiK, PetrovitchH, etal. Theassociationbetween midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995;274:1846-1851.
38. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neuro-biol Aging. 2000;21:49-55.
39. Korf ES, White LR, Scheltens P, et al. Midlife blood pressure and the risk of hippocampal atrophy: The Honolulu Asia Aging Study. Hypertension. 2004;44:29-34.
40. Knopman DS, Mosley TH Jr, Bailey KR, et al. Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J Neurol Sci. 2008; 271:53-60.